Literature DB >> 16941234

Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.

Wojciech Krzyzanski1, Jacek Dmochowski, Nobuko Matsushima, William J Jusko.   

Abstract

The application of D-optimization and the assessment of bias and precision of parameter estimates for four basic pharmacodynamic (PD) indirect response (IDR) models for ascending doses was examined using simulated data. While D-optimization provided four sampling times, each IDR model was used to generate eight data points per dose level. The PD parameters were: input rate constant (k (in)), disposition rate constant (k (out)), capacity constant (I (max) or S (max)), and sensitivity constant (IC (50) or SC (50)). A monoexponential pharmacokinetic function was applied with single doses increased by a factor of 10 to generate responses that vary from weak to fully saturable. For each dose, 100 replications of response data were simulated using independent normally distributed errors of CV = 20%. The original IDR model was fitted and PD parameters estimated. Histograms and descriptive statistics were generated. All parameters exhibited asymmetric distributions with positive coefficients of skewness except for I (max). Higher doses resulted in unbiased estimates of all PD parameters. The precision of parameter estimates improved with increasing doses except for IC (50) and SC (50) indicating that a single dose experimental design cannot be corrected by increasing dose in order to improve precision of estimates of IC (50) or SC (50). Highest variability was for IC (50) and SC (50) parameters. This study provides new insights into optimum study designs and recovery of parameters for basic IDR models.

Mesh:

Substances:

Year:  2006        PMID: 16941234     DOI: 10.1007/s10928-006-9028-y

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  8 in total

Review 1.  Diversity of mechanism-based pharmacodynamic models.

Authors:  Donald E Mager; Elzbieta Wyska; William J Jusko
Journal:  Drug Metab Dispos       Date:  2003-05       Impact factor: 3.922

2.  Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?

Authors:  S Dutta; Y Matsumoto; W F Ebling
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

3.  Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

4.  Characterization of four basic models of indirect pharmacodynamic responses.

Authors:  A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

5.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

6.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

7.  Physiologic indirect response models characterize diverse types of pharmacodynamic effects.

Authors:  W J Jusko; H C Ko
Journal:  Clin Pharmacol Ther       Date:  1994-10       Impact factor: 6.875

8.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08
  8 in total
  7 in total

1.  An example of optimal phase II design for exposure response modelling.

Authors:  Alan Maloney; Marloes Schaddelee; Jan Freijer; Walter Krauwinkel; Marcel van Gelderen; Philippe Jacqmin; Ulrika S H Simonsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-09-25       Impact factor: 2.745

2.  Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.

Authors:  Sihem Ait-Oudhia; Jean-Michel Scherrmann; Wojciech Krzyzanski
Journal:  J Pharmacol Exp Ther       Date:  2010-05-25       Impact factor: 4.030

3.  Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans.

Authors:  Wojciech Krzyzanski; Sukyung Woo; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-03-25       Impact factor: 2.745

4.  Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.

Authors:  Wojciech Krzyzanski; Juan Jose Perez-Ruixo; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-06-13       Impact factor: 2.745

5.  D-optimal designs for parameter estimation for indirect pharmacodynamic response models.

Authors:  Leonid A Khinkis; Wojciech Krzyzanski; William J Jusko; William R Greco
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-11-11       Impact factor: 2.745

Review 6.  Lifespan based indirect response models.

Authors:  Wojciech Krzyzanski; Juan Jose Perez Ruixo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-03       Impact factor: 2.745

7.  Methods of utilizing baseline values for indirect response models.

Authors:  Sukyung Woo; Dipti Pawaskar; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-21       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.